{"id":"https://openalex.org/W3212923359","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.253","title":"253 PD1 and LAG3 converge to limit polyfunctionality and systemic immunity","display_name":"253 PD1 and LAG3 converge to limit polyfunctionality and systemic immunity","publication_year":2021,"publication_date":"2021-11-01","ids":{"openalex":"https://openalex.org/W3212923359","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.253","mag":"3212923359"},"language":"en","primary_location":{"id":"doi:10.1136/jitc-2021-sitc2021.253","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.253","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.253","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A274.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A274.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078884068","display_name":"Lawrence Peter Andrews","orcid":"https://orcid.org/0000-0002-4923-142X","observed_orcids":["https://orcid.org/0000-0002-4923-142X"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence Andrews","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088868602","display_name":"Sasikanth Manne","orcid":"https://orcid.org/0000-0001-9856-0871","observed_orcids":["https://orcid.org/0000-0001-9856-0871"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sasikanth Manne","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057824723","display_name":"E. John Wherry","orcid":"https://orcid.org/0000-0003-0477-1956","observed_orcids":["https://orcid.org/0000-0003-0477-1956"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"E John Wherry","raw_affiliation_strings":["University of Pennsylvania, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pennsylvania, Philadelphia, PA, USA","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008106149","display_name":"Creg J. Workman","orcid":"https://orcid.org/0000-0002-9964-9509","observed_orcids":["https://orcid.org/0000-0002-9964-9509"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Creg Workman","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, USA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5001000053","display_name":"Dario A.A. Vignali","orcid":"https://orcid.org/0000-0002-2771-5992","observed_orcids":["https://orcid.org/0000-0002-2771-5992"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dario Vignali","raw_affiliation_strings":["University of Pittsburgh, Pittsburgh, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, Pittsburgh, USA","institution_ids":["https://openalex.org/I170201317"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":{"value":2490,"currency":"USD","value_usd":2490},"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A274","last_page":"A274"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9887999892234802,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pd-1","display_name":"PD-1","score":0.9319999814033508},{"id":"https://openalex.org/keywords/lag-3","display_name":"LAG-3","score":0.8859999775886536},{"id":"https://openalex.org/keywords/dual-checkpoint-blockade","display_name":"dual checkpoint blockade","score":0.5699999928474426},{"id":"https://openalex.org/keywords/cd8-t-cell-exhaustion","display_name":"CD8+ T cell exhaustion","score":0.7960000038146973},{"id":"https://openalex.org/keywords/tumor-infiltrating-t-cells","display_name":"tumor-infiltrating T cells","score":0.8579999804496765},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8370000123977661},{"id":"https://openalex.org/keywords/adoptive-t-cell-therapy","display_name":"adoptive T cell therapy","score":0.7570000290870667},{"id":"https://openalex.org/keywords/conditional-knock-in-mice","display_name":"conditional knock-in mice","score":0.7200000286102295},{"id":"https://openalex.org/keywords/b16-melanoma","display_name":"B16 melanoma","score":0.7910000085830688},{"id":"https://openalex.org/keywords/t-cell-proliferation","display_name":"T cell proliferation","score":0.7300000190734863},{"id":"https://openalex.org/keywords/t-cell-polyfunctionality","display_name":"T cell polyfunctionality","score":0.5590000152587891},{"id":"https://openalex.org/keywords/systemic-immunity","display_name":"systemic immunity","score":0.6650000214576721},{"id":"https://openalex.org/keywords/tumor-immune-tolerance","display_name":"tumor immune tolerance","score":0.30799999833106995},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.3149999976158142}],"concepts":[{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.6492059826850891},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5650634169578552},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.524314284324646},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5068195462226868},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.4738766849040985},{"id":"https://openalex.org/C90375314","wikidata":"https://www.wikidata.org/wiki/Q3537484","display_name":"Adoptive cell transfer","level":4,"score":0.44655293226242065},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.44180989265441895},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.41709479689598083},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.36070960760116577},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2407352328300476},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.06982839107513428},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1136/jitc-2021-sitc2021.253","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.253","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.253","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A274.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},{"id":"pmh:oai:doaj.org/article:732746760d34456ca5a5ce8a0113249e","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/732746760d34456ca5a5ce8a0113249e","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1136/jitc-2021-sitc2021.253","doi":"https://doi.org/10.1136/jitc-2021-sitc2021.253","is_oa":true,"landing_page_url":"https://doi.org/10.1136/jitc-2021-sitc2021.253","pdf_url":"https://jitc.bmj.com/content/jitc/9/Suppl_2/A274.full.pdf","source":{"id":"https://openalex.org/S2754803477","display_name":"Journal for ImmunoTherapy of Cancer","issn_l":"2051-1426","issn":["2051-1426"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Regular and Young Investigator Award Abstracts","raw_type":"proceedings-article"},"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3212923359.pdf","grobid_xml":"https://content.openalex.org/works/W3212923359.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4313373865","https://openalex.org/W4308400002","https://openalex.org/W2328005536","https://openalex.org/W2139591061","https://openalex.org/W4401420347","https://openalex.org/W2329257658","https://openalex.org/W2482411008","https://openalex.org/W1920088397","https://openalex.org/W2739997406","https://openalex.org/W4416088315"],"abstract_inverted_index":{"Background":[0],"Targeting":[1],"PD1":[2,31,66,116,238,245,293,324],"with":[3,30,110,161,201,227,234,312,386],"monoclonal":[4],"antibodies":[5],"has":[6,219],"yielded":[7],"clinical":[8],"success":[9],"across":[10],"a":[11,39,138,162,206,274,337,359],"variety":[12],"of":[13,166,209,237,260,279,333,361,376],"tumor":[14,140,181,218,284,348],"types,":[15],"yet":[16],"overcoming":[17],"inhibitory":[18],"receptor":[19],"(IR)-mediated":[20],"tolerance":[21],"is":[22,56,63],"essential":[23],"to":[24,70,100,114,141,146,257,300],"improve":[25],"immunotherapeutic":[26],"responses.":[27],"LAG3":[28,68,326],"co-expresses":[29],"on":[32,336],"CD8+":[33,54,72,101,122,126,168,187,198,211,250,289,306,340,363],"tumor-infiltrating":[34],"T":[35,102,123,148,307,341],"cells":[36,103,128,170,200,213,291,308],"(TIL),":[37],"signifying":[38],"highly":[40],"exhausted":[41],"phenotype,":[42],"and":[43,67,83,131,315,325,350,366],"dual":[44],"PD1/LAG3":[45,87],"blockade":[46],"in":[47,183,194,345,353,379],"C57BL/6":[48,135],"mice":[49,91,107,136,172,184,195,215,252],"enhances":[50],"antitumor":[51,76],"immunity.":[52,77],"As":[53],"TIL":[55,60,73,364],"the":[57,81,111,152,217,261,270,283,287,374,380],"dominant":[58],"LAG3-expressing":[59],"population,":[61],"it":[62],"hypothesized":[64],"that":[65,230,264,286,373],"synergizes":[69],"limit":[71,327],"function":[74],"controlling":[75],"Methods":[78],"To":[79],"understand":[80],"cellular":[82],"mechanistic":[84],"basis":[85],"for":[86],"synergy,":[88],"conditional":[89],"knock-in":[90],"\u201dsurgically":[92],"dissect\u201d":[93],"Pdcd1":[94],"and/or":[95,117,246],"Lag3":[96],"floxed":[97],"alleles":[98],"restricted":[99],"expressing":[104],"E8ICre.GFP.":[105],"These":[106,368],"were":[108,129,253,309],"crossed":[109],"Pmel":[112,127,169,188,199,212,251,290],"transgene":[113],"assess":[115,147,258],"LAG3-sufficient":[118,247],"or":[119,145,239,241,248,294,296],"deficient":[120,249],"gp100-specific":[121],"cell":[124,149,342],"populations.":[125],"isolated":[130],"adoptively":[132,267],"transferred":[133,268],"into":[134,171,214,269],"harboring":[137],"B16-gp100-overexpressing":[139],"observe":[142],"therapeutic":[143,157,207,225],"benefit,":[144,226],"functionality":[150,365],"within":[151,282],"tumor.":[153],"Results":[154],"While":[155],"little":[156],"benefit":[158],"was":[159,179,191,231],"observed":[160,318],"prophylactic":[163],"adoptive":[164,235,355],"transfer":[165,236,356],"wild-type":[167],"which":[173,190],"then":[174],"received":[175],"B16-gp100":[176,347],"tumor,":[177],"there":[178],"reduced":[180,346],"growth":[182,349],"receiving":[185,196],"PD1-deficient":[186],"cells,":[189],"further":[192],"enhanced":[193,228,301,351,362],"PD1/LAG3-deficient":[197,210,288,305],"long-term":[202],"tumor-free":[203],"survival.":[204],"Likewise,":[205],"administration":[208],"once":[216],"been":[220],"established":[221],"showed":[222],"an":[223,354],"initial":[224],"survival,":[229],"not":[232],"demonstrated":[233],"LAG3-deficient,":[240,295],"wild-type,":[242,297],"counterparts.":[243],"Each":[244],"differentially":[254],"congenically":[255],"marked":[256],"each":[259],"four":[262],"genotypes":[263],"can":[265],"be":[266],"same":[271],"host":[272],"as":[273,331,358],"\u201dquad":[275],"transfer\u201d":[276],"system.":[277],"Recovery":[278],"these":[280],"populations":[281],"show":[285],"out-compete":[292],"counterparts":[298],"due":[299],"proliferation":[302],"(Ki67/BrdU).":[303],"Furthermore,":[304],"more":[310],"functional":[311],"increased":[313],"IFNg":[314],"GzmB":[316],"release":[317],"by":[319],"flow":[320],"cytometry.":[321],"Conclusions":[322],"Overall":[323],"anti-tumor":[328],"immune":[329],"effects":[330],"removal":[332],"both":[334],"IRs":[335],"gp100":[338],"antigen-specific":[339],"population":[343],"results":[344,369],"survival":[352],"model,":[357],"result":[360],"proliferation.":[367],"provide":[370],"striking":[371],"evidence":[372],"development":[375],"anti-LAG3":[377],"agents":[378],"clinic":[381],"would":[382],"yield":[383],"improved":[384],"responses":[385],"anti-PD1.":[387]},"counts_by_year":[],"updated_date":"2026-11-02T09:45:03.842371","created_date":"2021-11-22T00:00:00"}